The German Digital Healthcare Act (DVG) has formed the basis for improved healthcare in Germany through digitalisation and innovation since its introduction at the end of 2019. Under the DVG and the Digital Health Applications Ordinance (DiGAV), doctors are now able to prescribe digital healthcare applications (DiGAs) to patients, provided the apps are approved as medical devices. Prescriptions of this nature are covered by German health insurers. Against this backdrop, the IT service provider adesso has set up a new joint venture in partnership with the medical devices manufacturer medi.
Press release
Dortmund/Bayreuth |
medi and adesso set up HEALAY joint venture
New milestone in digital health applications: adesso and the Bayreuth-based medical devices manufacturer medi have founded a new joint venture called HEALAY. Based in Frankfurt, the new joint venture will focus on developing and marketing innovative digital health applications in the medical devices market.
Christoph Schmitz of medi will lead the new start-up in collaboration with adesso’s Thomas Starke. “Our joint venture HEALAY paves the way for high-performance innovations in the digitalisation of the healthcare industry,” said Christoph Schmitz on the formation of the new company. “With our outstanding access to technology expertise and development capacity, we aim to bring digital healthcare applications to market. In this way, HEALAY supports medi and other partners in getting closer to important target groups and substantially expanding their own value proposition.”
Christoph Schmitz is Head of Digital Health Transformation at the medical device manufacturer medi. He will manage HEALAY together with Thomas Starke. (Source: medi)
Treatment of the future: prescription apps
HEALAY will work closely with adesso and medi to expand its development of apps and digital services moving forward. adesso already develops DiGAs, mostly for start-ups, and is set to continue on this pathway in cooperation with HEALAY.
“The digital medical market is developing promisingly from our perspective,” says Thomas Starke from adesso. “We need to digitalise and personalise treatment to improve healthcare quality while including patients more actively in their course of treatment. DiGAs are an important step in the right direction, and adesso will be contributing its wealth of expertise and significant capacities to the development and operation of digital applications.”
Dr. Thorsten Vogel heads the Health business unit at adesso with the Life Sciences specialty, which Thomas Starke, new HEALAY Managing Director, will continue to be responsible for at adesso. (Source: private)
The medical devices manufacturer medi offers a full range of medical device concepts and associated services to help treat issues such as venous disorders, lymphoedema, lipedema or gonarthrosis. Christoph Schmitz of medi explains the reasons for forming the joint venture with adesso: “With DiGAs, we are forging a link with our core business in the same indication areas. This allows us to move even closer to our patients, with our holistic concepts increasing adherence and, in doing so, raising the treatment success rate. The formation of HEALAY is a key milestone in the digital transformation of our company.”
medi and adesso: joint management
HEALAY CEO Christoph Schmitz is Head of Digital Health Transformation at medi. Co-CEO Thomas Starke is Head of Life Sciences at adesso SE.
Do you have any questions?
Do you have questions about our press service or a specific request? Please contact me.
CEO & Chairman Hansjörg Süess +41 58 520 97 10